Skip to main content
Launch offer40% off your first paymentEnds 31 DecemberSee plans
Keros Therapeutics logo

Keros Therapeutics

Biotech & Pharmaceuticals
WebsiteLinkedIn

At Keros, our mission is to deliver significant clinical benefit to a wide range of patients with disorders that are linked to dysfunctional signaling of the transforming growth factor-beta (TGF-ß) family of proteins. With a focus on developing differentiated product candidates that are designed to alter TGF-ß signaling, we aim to target the pathways critical for the growth, repair and maintenance of blood cells and a number of tissues, including bone, skeletal muscle, adipose and heart tissue.

Open roles
1
Company size
51 - 200 employees
Headquarters
1050 Waltham Street, Suite 302, Lexington, MA 02421

Follow Keros Therapeutics

Create an exact-company alert for on-site matches and optional daily email.

Open roles